Intravenous Infusions Balance Sheet

Financials in millions GHS. Fiscal year is January - December.

Millions GHS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.02	1.49	0.29	0.95	0.81
Cash & Short-Term Investments	0.02	1.49	0.29	0.95	0.81
Cash Growth	-98.59%	405.98%	-69.17%	18.07%	-16.05%
Accounts Receivable	4.93	10.23	15.07	15.13	15.74
Other Receivables	2.62	2.41	1.44	1.77	1.79
Receivables	7.55	12.63	16.51	16.9	17.53
Inventory	4.53	6.09	6.26	6.63	7.65
Prepaid Expenses	0.44	0.06	0.09	0.07	0.09
Total Current Assets	12.55	20.26	23.15	24.55	26.08
Property, Plant & Equipment	25.88	24.5	23.26	22.21	20.41
Long-Term Investments	0.01	0.01	0.01	-	-
Other Intangible Assets	0.06	0.07	0.07	0.06	0.06
Long-Term Deferred Tax Assets	0.6	-	-	-	-
Total Assets	39.09	44.84	46.49	46.82	46.55
Accounts Payable	8.49	12.21	9.33	8.52	7.1
Accrued Expenses	0.07	0.05	0.18	0.18	0.2
Short-Term Debt	0.42	0.87	1.23	1.64	-
Current Portion of Long-Term Debt	3.94	3.94	3.94	4.09	2.54
Current Portion of Leases	0.01	0.01	0.02	0.02	0.01
Current Income Taxes Payable	-	-	0	-	-
Other Current Liabilities	9.48	7.31	6.15	6.96	4.15
Total Current Liabilities	22.43	24.4	20.86	21.4	14
Long-Term Debt	5.35	3.94	7.88	10.36	13.81
Long-Term Leases	0.03	0.03	0.03	0.03	0.03
Long-Term Deferred Tax Liabilities	-	0.55	0.39	0.25	0.41
Total Liabilities	27.81	28.93	29.17	32.04	28.26
Common Stock	11.63	11.63	11.63	11.63	11.63
Additional Paid-In Capital	2.1	2.1	2.1	2.1	2.1
Retained Earnings	-2.45	2.18	3.59	1.05	4.56
Shareholders' Equity	11.28	15.91	17.32	14.78	18.29
Total Liabilities & Equity	39.09	44.84	46.49	46.82	46.55
Total Debt	9.77	8.81	13.12	16.13	16.39
Net Cash (Debt)	-9.75	-7.32	-12.83	-15.18	-15.58
Net Cash Per Share	-0.04	-0.03	-0.05	-0.06	-0.06
Filing Date Shares Outstanding	274.41	274.41	274.41	274.41	274.41
Total Common Shares Outstanding	274.41	274.41	274.41	274.41	274.41
Working Capital	-9.88	-4.14	2.29	3.15	12.08
Book Value Per Share	0.04	0.06	0.06	0.05	0.07
Tangible Book Value	11.22	15.84	17.25	14.72	18.23
Tangible Book Value Per Share	0.04	0.06	0.06	0.05	0.07
Land	3.74	3.74	3.74	3.74	2.66
Machinery	8.79	8.79	8.74	5.59	5.48
Construction In Progress	20.05	18.12	16.31	17.63	16.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.